Arketamine

R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine

Comparative pharmacology of the ketamine isomers: studies in volunteers

R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects

Intravenous arketamine for treatment-resistant depression: Open-label pilot study

Depression as a neuroendocrine disorder: Emerging neuropsychopharmacological approaches beyond monoamines

Impact of age on optimal dose of antidepressants

Method of treating pain and depression using a hybrid mixture of s-ketamine and r-ketamine

Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority …

Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)-and (R)-ketamine in healthy volunteers using positron emission tomography …

Metabolism of ketamine stereoisomers by human liver microsomes

Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man

Lack of dopamine D 1 receptors in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model

Glutamate Modulators in Major Depressive Disorder

Psychedelics

Psychedelics encyclopedia

Psychedelics and the human receptorome

Psychedelics and the essential importance of context

Psychedelics and mental health: a population study

Psychedelics as medicines: an emerging new paradigm

Psychedelics: Where we are now, why we got here, what we must do

Psychedelics promote structural and functional neural plasticity

REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics

How do psychedelics work?

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor